CUSIP: 29604W108
Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
4,603,787
-
Share change
-
+4,533,787
-
Total reported value
-
$101,378,000
-
Price per share
-
$22.02
-
Number of holders
-
10
-
Value change
-
+$99,839,000
-
Number of buys
-
9
Quarterly Holders Quick Answers
What is CUSIP 29604W108?
CUSIP 29604W108 identifies PHXM - ERYTECH PHARMA - SPONSORED ADR in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29604W108:
Institutional Holders of ERYTECH PHARMA - SPONSORED ADR (PHXM) as of Q4 2017
As of 31 Dec 2017,
ERYTECH PHARMA - SPONSORED ADR (PHXM) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,603,787 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, NEA Management Company, LLC, BVF INC/IL, SPHERA FUNDS MANAGEMENT LTD., Delek Group, Ltd., MILLENNIUM MANAGEMENT LLC, JANE STREET GROUP, LLC, UBS Group AG, MACQUARIE GROUP LTD, and EDMOND DE ROTHSCHILD HOLDING S.A..
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.